News

Reclaim Your Losses: Join the TFI International Class Action

Reclaim Your Losses: Join the TFI International Class Action

Join the Movement to Recover Losses with TFI International

Are you a shareholder of TFI International Inc. (NYSE: TFII) who has seen a decrease in your investment value? If so, you are not alone. Many individuals have lost money amidst troubling allegations surrounding the company's operations, particularly between April 26, 2024 and February 19, 2025. Understanding your rights as an investor is essential at this time.

Class Action Overview

The Gross Law Firm has initiated a class action lawsuit to seek recovery for investors who purchased shares of TFI International during the specified class period. If you have experienced financial loss, consider reaching out to the firm for possible lead plaintiff appointment or to participate in the case. Registration does not require lead plaintiff status.

Key Dates

Investors should mark their calendars for the crucial deadline of May 13, 2025. This is the date by which shareholders must act to be included in the class action suit. Timely registration ensures you remain informed throughout the case's lifecycle, and there is no cost associated with participating.

Understanding the Allegations

The allegations claim that during the class period, TFI International made multiple misleading statements that did not accurately reflect the company's true financial condition. Among these claims, it is alleged that:

  • The company was losing small and medium business customers;
  • TForce revenue was declining;
  • There were difficulties in managing costs;
  • The profitability of TFI's largest business segment was decreasing;
  • The positive statements from leadership about the company's performance lacked foundation.

These assertions highlight the need for investors to be cautious and informed about their investments, especially when navigating potential legal actions.

Next Steps for Investors

To actively participate in the recovery process, shareholders should register with The Gross Law Firm. Once registered, you will gain access to ongoing updates regarding the case, including vital information about court rulings and progress. The firm prioritizes keeping shareholders informed and involved throughout the litigation.

Why Choose The Gross Law Firm?

The Gross Law Firm stands out among class action law firms for its commitment to protecting the rights of investors. They strive to ensure that companies maintain ethical business practices and avoid fraudulent activities that can harm share prices. The firm’s goal is to help investors recover losses attributed to misleading corporate statements.

Contact Information

If you feel you have a case or would like to learn more about your options, don't hesitate to get in touch. The Gross Law Firm can guide you through the recovery process.

Contact:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Phone: (646) 453-8903

Frequently Asked Questions

What is the class action against TFI International about?

The class action is aimed at recovering losses for shareholders who invested in TFI International during a certain period, alleging misleading statements by the company.

Who can join the class action?

Shareholders who purchased shares of TFI International during the specified class period are encouraged to participate.

What is the deadline for registration?

The registration deadline for participating in the class action is May 13, 2025.

Is there any cost to participate?

There is no cost or obligation for shareholders to register and participate in the class action lawsuit.

How will I be updated on the case progress?

Once registered, you will receive updates throughout the lifecycle of the case, keeping you informed of all significant developments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Paulex Bio's PAL-119 Trials: A New Diabetes Frontier

Updated Category News Views 80

Chasing the Holy Grail in Diabetes Treatment The pursuit of a true remedy for diabetes is almost like hunting for the mythical beast—a challenge that's left plenty of contenders biting the dust over the years. Yet, here's Paulex Bio jumping right into the fray with their groundbreaking PAL-119. They're not just peddling another temporary fix like most on the market;...

Continue Reading
PRG Projects' London Studio Elevates Live Entertainment

Updated Category News Views 172

A New Stage for Creativity in London When the curtain rises on a fresh idea, it's often the unknowns that make or break a production. Now, with PRG Projects unveiling their spanking new Project Studio in London, the tech and creative worlds might just bridge their gap tighter than a stage curtain before showtime. London Welcomes PRG's Innovative Hub This isn't just...

Continue Reading
TriMas Streamlines Portfolio with Rapak Sale

Updated Category News Views 48

TriMas Sheds Rapak: A Strategic Move Here's a twist worth dissecting: TriMas Corporation (NASDAQ: TRS) has offloaded its subsidiary Rapak, LLC to the German industrial packaging giant, Ringmetall SE. This isn't just a business shuffle—it's a calculated pivot with eyes on sharpening the core business blade. As they announced from Bloomfield Hills, Michigan, this move...

Continue Reading
i-80 Gold's Q3 2026: Production Plans Unveiled

Updated Category News Views 31

Gold Miners on the Move: Eye on i-80 Wake up and smell the gold, folks. i-80 Gold is ramping up to increase its yearly gold production targets, aiming for a hefty 150,000 to 200,000 ounces by 2028. Now, if you’ve been around the block like me, you know these are the kind of numbers that get investors either shifting in their chairs or springing to their feet. A Brief...

Continue Reading
RD Technologies Ramps Up Cross-Border Payments

Updated Category News Views 185

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Continue Reading
Ascletis Showcases Bold Moves in Obesity Drug Arena

Updated Category News Views 163

If you’ve been watching the developments in the world of obesity treatments, Ascletis Pharma is a name you'd do well not to ignore. With ObesityWeek 2026 on the horizon, these folks aren’t just talking—they’re putting their preclinical cards on the table and they’re noteworthy. Unveiling Future Contenders Ascletis is gearing up to present some of their...

Continue Reading
Lincoln Avenue's Bold New Move: Affordable Senior Living

Updated Category News Views 33

A New Senior Housing Era Begins in Channahon If there's one thing the affordable housing game loves, it's the mix of ambition and grit—both of which Lincoln Avenue Communities (LAC) brings to the table with The Talia. This latest project in Channahon, Illinois, marks their fourth groundbreaking in the state, cementing LAC's place as a key player in providing quality...

Continue Reading
Kim Dunbar Sheds Light on Online Personalized Learning

Updated Category News Views 11

Picture a classroom without walls, the teacher always available, and students moving at their own pace. Sounds utopian, right? Well, Virtual Public School Expert Kim Dunbar is making sense of this approach at SC Whitmore School in Columbia, South Carolina, as she explains how this works in an online high school. Mastery-Based Learning: Beyond the Conventional Rigid...

Continue Reading
Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026

Updated Category News Views 23

Neurocrine's Triple-Digit Surge Neurocrine Biosciences is on a tear, pushing its revenue up to a jaw-dropping $1.1 billion in Q3 2026—a hefty 41% leap from the previous year. Frankly, you can't ignore those numbers. INGREZZA, which is practically becoming a cash cow, did $801 million alone, rising 17% year over year. This rides the wave of prescription surges and solid...

Continue Reading
Dr. Huang's Honorary Degree Caps Global Impact Journey

Updated Category News Views 41

Recognition from Alma Mater Puts a Bow on a Storied Career When someone ventures out into the world and leaves a mark across continents, it’s a remarkable feat. It’s even more heartening when the place that helped shape them gets to extend a nod of recognition. Dr. Charles Huang, the mastermind behind Pasaca Capital, just unwound a new layer to his multicolored life...

Continue Reading
/neurocrine-biosciences-hits-1-billion-mark-in-q3-2026-540185-/" title="Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026 - Continue Reading" aria-label="Continue reading: Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026"> Continue Reading